|
業務類別
|
Biotechnology |
|
業務概覽
|
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients. |
| 公司地址
| 12278 Scripps Summit Drive, San Diego, CA, USA, 92131 |
| 電話號碼
| +1 858 875-1800 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.fatetherapeutics.com |
| 員工數量
| 161 |
| Dr. Bahram Valamehr, M.B.A.,PhD |
Director, President and Chief Executive Officer |
美元 525.00K |
26/02/2026 |
| Ms. Cindy R. Tahl, J.D. |
Chief Legal and Compliance Officer and Corporate Secretary |
美元 500.00K |
17/04/2025 |
| Mr. Kamal Adawi, M.B.A.,M.S. |
Treasurer, Chief Financial Officer and Principal Accounting Officer |
-- |
26/02/2026 |
|
|
| Dr. Bahram Valamehr, M.B.A.,PhD |
Director, President and Chief Executive Officer |
26/02/2026 |
| Dr. Karin Jooss, PhD |
Independent Director |
26/02/2026 |
| Mr. Michael Lee |
Independent Director |
26/02/2026 |
| Dr. Robert S. Epstein, M.D.,M.S. |
Independent Director |
26/02/2026 |
| Dr. William H. Rastetter,PhD |
Chairman of the Board |
26/02/2026 |
| Mr. Matthew C. Abernethy |
Independent Director |
26/02/2026 |
| Dr. Shefali Agarwal, M.D.,M.P.H. |
Independent Director |
26/02/2026 |
| Dr. Yuan Xu, PhD |
Independent Director |
26/02/2026 |
|
|
|
|
